ArticleBrain : a journal of neurology2019

Reply: Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.

Océane Landon-Cardinal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.